Full-Time

Staff Accountant

Posted on 9/25/2025

Ottobock

Ottobock

1,001-5,000 employees

Provider of prosthetics, orthotics, wheelchairs, exoskeletons

No salary listed

Burlington, ON, Canada

Hybrid

Hybrid work schedule.

Category
Accounting (3)
, ,
Required Skills
SAP Products
Excel/Numbers/Sheets
Requirements
  • University degree in Business/Finance with advanced degree or professional designation (such as: CA, CPA, CMA, CMT)
  • 2-3 years of experience and knowledge of all aspects of Accounting
  • Experience in a manufacturing and/or medical device environment preferable
  • Good understanding of Accounting and Corporate Finance
  • Understanding of financial policies and practices and Canada GAAP; and of German IFRS a plus
  • Thorough knowledge of all relevant Federal, Provincial and local requirements regarding financial records, pension, profit sharing, tax and the like is essential
  • Strong knowledge of Microsoft Office, Excel expert (V-look ups, pivot tables, macros, VBA a plus)
  • Knowledge of SAP or other ERP system
  • Strong verbal and written communication skills; ability to interface effectively with all levels of the organization
Responsibilities
  • Responsible for the full Accounting Cycle
  • Prepare and record journal entries in the general ledger
  • Assist in the preparation of monthly, quarterly, and annual financial statements
  • Reconcile bank statements and general ledger accounts to ensure accuracy
  • Maintain and update financial records in compliance with company policies and accounting standards
  • Complete International Finance Reporting Standards (IFRS) adjustments
  • Complete profit & loss statements
  • Complete banking transactions
  • Responsible for month-end and year-end closing activities, including accruals and adjustments
  • Assist in preparing financial reports for management review
  • Complete reconciliations
  • Work closely with auditors during internal and external audits by providing necessary documentation
  • Assist with all internal and external audit reviews
  • Ensure compliance with financial policies, procedures, and regulatory requirements
  • Assist in implementing and maintaining internal controls to safeguard company assets
Desired Qualifications
  • Experience in a manufacturing and/or medical device environment preferable
  • Understanding of German IFRS a plus
  • PowerQuery and PowerBI or similar data management and visualization experience a plus

Ottobock is a global producer of orthopedic technology, focusing on prosthetics, orthotics, wheelchairs, and exoskeletons. Its products range from basic devices to advanced, microprocessor-controlled prosthetics and ergonomic exoskeletons that help people move more easily and stay independent. These devices work by using sensors, motors, and smart controls to adapt to a user’s movement, pace, and terrain, providing ankle and knee assistance or full upper- and lower-limb support. compared with others, Ottobock stands out as a family-owned company with a long history, a broad international footprint in about 60 countries, a large workforce, and a strong commitment to social responsibility, including a long-running partnership with the Paralympic Games. Its core goal is to improve mobility and quality of life for people with disabilities by delivering reliable, high-quality mobility solutions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Duderstadt, Germany

Founded

1919

Simplify Jobs

Simplify's Take

What believers are saying

  • IPO raised €702-808M in October 2025, shares surged 11% to €73.
  • $5M Blue Arbor investment advances FDA breakthrough RESTORE system.
  • SuitX acquisition in 2021 expands exoskeletons into industrial markets.

What critics are saying

  • Össur's POWER KNEE erodes C-Leg share by 15% via AI gait prediction.
  • Deren Bionics captures 25% Asia-Pacific orthotics with cheaper prosthetics.
  • Näder family succession dispute forces share sales, crashing stock 25-40%.

What makes Ottobock unique

  • Ottobock leads globally in prosthetics as world market leader since 1919.
  • Advanced microprocessor prosthetics like C-Leg set industry benchmarks.
  • Long-term Paralympic partnership drives mobility innovation worldwide.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

401(k) Company Match

100% company-paid short & long-term disability

Company News

Morningstar
Feb 26th, 2026
Blue Arbor secures $5M from Ottobock to advance FDA breakthrough prosthetic control system

Blue Arbor Technologies has secured a $5 million investment from Ottobock, the global prosthetics leader, to advance its RESTORE Neuromuscular Interface System. Ottobock will lead Blue Arbor's Series A financing and hold a board seat. The FDA breakthrough-designated RESTORE System provides a fully implanted neuromuscular interface connecting advanced prostheses directly to patients' residual muscles and peripheral nerves. It enables independent, simultaneous control of fingers, wrist and elbow, with trials demonstrating stable signal capture for over five years. In December 2025, surgeons at the Medical University of Vienna completed the first-in-human RESTORE procedure. Within days, the patient demonstrated functional use with an Ottobock prosthetic. Founded by Drs Paul Cederna, Theodore Kung and Alex Vaskov, Blue Arbor has been awarded over $60 million in research grants and published more than 200 peer-reviewed papers.

Business Wire
Feb 26th, 2026
Blue Arbor Technologies Announces Strategic Partnership with Ottobock and $5 Million Investment to Advance RESTORE™ Neuromuscular Interface System

Blue Arbor Technologies announces $5 million investment by Ottobock to advance RESTORE™ System, designed to enable intuitive prosthetic control

De Tijd
Oct 24th, 2025
Onward Raises €50.85M from Investors

Onward has completed its capital round, securing €50.85 million from a group of major investors.

Investing.com
Oct 17th, 2025
Ottobock IPO Shares Stabilize at €66

Ottobock SE & Co. KGaA shares have been stabilizing since their IPO on October 14, with trading starting at €66.00. The lowest price reached was €64.50 on October 17. Stabilization measures, managed by Goldman Sachs Bank Europe SE, have been conducted daily across multiple trading venues, including XETRA and the Frankfurt Stock Exchange. The base offering included 10,640,151 shares. The shares are trading under ISIN DE000BCK2223.

Bloomberg L.P.
Oct 9th, 2025
Ottobock Shares Rise After Biggest German IPO of 2025

Ottobock SE & Co. shares rose in the prosthetics firm’s debut trading session in Frankfurt on Thursday, after the biggest initial public offering in Germany in more than a year.

INACTIVE